InvestorsHub Logo
Followers 44
Posts 16476
Boards Moderated 0
Alias Born 09/16/2012

Re: None

Friday, 11/10/2023 6:13:05 PM

Friday, November 10, 2023 6:13:05 PM

Post# of 708506
>>THIO has been granted an ODD from the FDA for treatment of glioblastoma, according to MAIA Biotechnology, THIO’s manufacturer.1 The ODD designation provides incentives to make drug development for rare diseases more attainable, including up to 7 years of market exclusivity and tax credits.


https://www.targetedonc.com/view/fda-grants-orphan-drug-designation-to-thio-for-glioblastoma
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News